2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1598095085 MD
Verify on CMS →

GIANMARCO VIZZERI, MD

Glaucoma Specialist (Ophthalmology) Physician in GALVESTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 510 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
MIPS score
74.9614/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$25.3
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

GIANMARCO VIZZERI, MD reported a CMS MIPS final score of 74.9614/100 — below the 83.1 national average — and filed 3,056 Medicare Part D claims in 2023.

74.9614/100
MIPS score · -8 vs avg
3K
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

GIANMARCO VIZZERI, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 12th percentile higher than 12% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

GIANMARCO VIZZERI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about GIANMARCO VIZZERI, MD?

Below national average

NPI registry status

Active

Issued 01/05/2010

NPI 1598095085

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

3,056 3% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

74.9614/100 8.138599999999997% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Texas

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Texas providers

Texas providers

Glaucoma Specialist (Ophthalmology) Physician share within Texas

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within Texas

Medicare quality performance — MIPS

GIANMARCO VIZZERI, MD's 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

Below national average
MIPS Final Score
74.9614/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 74.9614/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 74.9614/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GIANMARCO VIZZERI, MD appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding MD credentials at 301 UNIVERSITY BLVD, GALVESTON, TX, 77555, with a listed phone of (409) 772-2222. NPI 1598095085 was issued on 01/05/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what VIZZERI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 3,056 prescription claims written by this provider, covering 510 Medicare beneficiaries and totaling roughly $182K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.9614/100 for the 2023 performance year (Quality 73.7789, Cost 47.7591), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

301 UNIVERSITY BLVD
GALVESTON, TX 77555

Provider Details

NPI 1598095085
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials MD
Gender Male
NPI Issued 01/05/2010

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

74.9614
Final Score
Avg: 83.1
73.7789
Quality
47.7591
Cost
94
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where GIANMARCO VIZZERI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UTMB FACULTY GROUP PRACTICE
GALVESTON, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GIANMARCO VIZZERI, MD. Source: openpaymentsdata.cms.gov.

Total received

$25

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to GIANMARCO VIZZERI, MD. To verify GIANMARCO VIZZERI, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,056
Total Claims
$182K
Total Drug Cost
510
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
4,844
Total Day Supply
135,141
Generic Drug Cost
$65K

Patient Demographics

Average Patient Age
74.9 years
Avg HCC Risk Score
1.55
Gender Split
56% female / 44% male
Age Distribution
<65: 45, 65-74: 214, 75-84: 170, 85+: 81

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What GIANMARCO VIZZERI, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
1,170
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
384
Prednisolone Acetate
347
Brimonidine Tartrate
210
Moxifloxacin
Moxifloxacin Hcl
179
Ketorolac Tromethamine
162
Timolol Maleate
160
Lumigan
Bimatoprost
74
Dorzolamide Hcl
67
Travoprost
57

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How GIANMARCO VIZZERI, MD fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

GIANMARCO VIZZERI, MD's 3,056 claims are above the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as VIZZERI.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GIANMARCO VIZZERI, MD's specialty?
GIANMARCO VIZZERI, MD specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in GALVESTON, Texas. Credentials: MD.
How much does GIANMARCO VIZZERI, MD prescribe under Medicare Part D?
In 2023, GIANMARCO VIZZERI, MD wrote 3,056 Medicare Part D claims totaling $182K in drug costs for 510 beneficiaries.
What is GIANMARCO VIZZERI, MD's Medicare quality score?
GIANMARCO VIZZERI, MD has a CMS MIPS Final Score of 74.9614/100 (Quality: 73.7789, Cost: 47.7591). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is GIANMARCO VIZZERI, MD located?
GIANMARCO VIZZERI, MD is located at 301 UNIVERSITY BLVD, GALVESTON, TX, 77555. Phone: (409) 772-2222.
What is GIANMARCO VIZZERI, MD's NPI number?
GIANMARCO VIZZERI, MD's National Provider Identifier (NPI) is 1598095085, issued on 01/05/2010.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does GIANMARCO VIZZERI, MD prescribe most often?
Based on 2023 Medicare Part D data, GIANMARCO VIZZERI, MD's most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GIANMARCO VIZZERI, MD accept Medicare?
GIANMARCO VIZZERI, MD appears in CMS Medicare data with 3,056 Part D claims and 510 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GIANMARCO VIZZERI, MD's credentials?
GIANMARCO VIZZERI, MD's NPI is 1598095085 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology